Dansk Bioindustri ApS: Financial statements 2022
CVR: 37759147
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
Dansk Bioindustri ApS (CVR 37759147) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 46,612 and a net result of DKK 46,904 compared with DKK 0 the year before. Equity in the 2022 report amounted to DKK 46,904. The solvency ratio was 30.4%.
- Gross Profit
- DKK 46,612
- Profit/Loss
- DKK 46,904
- Equity
- DKK 46,904
- Total Assets
- DKK 154,172
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 47K | 47K | 47K | - |
| 2021 | - | - | 0 | 0 | - |
| 2020 | - | - | 0 | 0 | - |
| 2019 | - | 0 | 0 | 0 | - |
| 2018 | - | - | -40K | 0 | - |
Official annual report
Keep an eye on Dansk Bioindustri ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of November 1, 2022, John Mark Lawther is registered as adm. dir. of Dansk Bioindustri ApS.
As of November 1, 2022, Gunnar Kvistgaard has stepped down as director of Dansk Bioindustri ApS.
As of February 20, 2022, Gunnar Kvistgaard is registered as director of Dansk Bioindustri ApS.
As of February 20, 2022, Orla Møller Petersen has stepped down as director of Dansk Bioindustri ApS.
About Dansk Bioindustri ApS
Dansk Bioindustri ApS is a Danish company of the type Anpartsselskab based in Åbyhøj, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Orla Møller Petersen. The company is owned by DACWR ApS and Kennedy Consult & Education ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -2,559 the year before. Equity in the 2025 report amounted to DKK -11,598.